Drug Shortage Report for CELESTONE SOLUSPAN

Last updated on 2021-05-15 History
Report ID 136690
Drug Identification Number 00028096
Brand name CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE ACETATE BETAMETHASONE
Strength(s) 3MG 3MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR
Packaging size 5ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-05-04
Actual start date 2021-05-04
Estimated end date 2021-05-14
Actual end date 2021-05-14
Shortage status Resolved
Updated date 2021-05-15
Company comments
Health Canada comments
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-05-15 English Compare
v6 2021-05-14 English Compare
v5 2021-05-05 English Compare
v4 2021-05-04 English Compare
v3 2021-04-29 English Compare
v2 2021-04-01 French Compare
v1 2021-04-01 English Compare